Article Details
Retrieved on: 2022-06-13 19:04:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Treatment with ropeginterferon alfa-2b-njft induced low symptom burden and low phlebotomy requirement compared with best available treatment in ...
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here